AInvest★★★★★3-DAY FREE
Catch pre-market movers with AI signals.
Claim Trial
CDTX(Quitar la ciudad)
Cidara Therapeutics·NASDAQ
--
--(--)
Cidara Therapeutics (CDTX) Financial Statements
Cidara Therapeutics (CDTX) Cash Flow Statement
During Q3 2025, Cidara Therapeutics (CDTX) generated -40.62M in cash flow from operating activities, -176.47M from investing activities, and 160.00K from financing activities. Click to view the cash flow statement and track how funds are moving through the company.
Cash Flow
Q1,2014 | Q1,2015 | Q1,2016 | Q1,2017 | Q1,2018 | Q1,2019 | Q1,2020 | Q1,2021 | Q1,2022 | Q1,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | TTM |
|---|
Start Date | Jan 1, 2014 | Jan 1, 2015 | Jan 1, 2016 | Jan 1, 2017 | Jan 1, 2018 | Jan 1, 2019 | Jan 1, 2020 | Jan 1, 2021 | Jan 1, 2022 | Jan 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | -- |
End Date | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Net Cash Flows from Operating Activities | -410.00K -- | -6.05M -1376.10% | -10.89M -79.87% | -14.52M -33.36% | -14.72M -1.41% | -17.15M -16.47% | -15.13M +11.77% | -1.79M +88.15% | -23.61M -1216.68% | -10.90M +53.84% | -12.72M -- | -6.64M +39.03% | -103.78M -- | -36.70M -- | -29.41M -131.21% | -21.95M -230.37% | -40.96M +60.53% | -40.62M -10.68% | -132.94M -- |
Net Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -3.21M -- | -10.33M -- | -91.21M -- | -15.98M -- | -52.31M -1527.98% | -23.48M -127.39% | -25.72M +71.80% | -83.23M -420.69% | -184.74M -- |
Depreciation and Amortization | 10.00K -- | 97.00K +870.00% | 142.00K +46.39% | 178.00K +25.35% | 144.00K -19.10% | 88.00K -38.89% | 71.00K -19.32% | 58.00K -18.31% | 297.00K +412.07% | 507.00K +70.71% | 39.00K -- | 56.00K -88.95% | 57.00K -- | 61.00K -- | 59.00K +51.28% | 49.00K -12.50% | 27.00K -52.63% | 28.00K -54.10% | 163.00K -- |
Stock-based Compensation | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 830.00K -- | 795.00K -- | 703.00K -- | 751.00K -- | 1.66M +99.76% | 1.74M +118.99% | 2.96M +320.34% | 3.17M +322.24% | 9.53M -- |
Interest Income(expense) | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 5.00K -- | 16.00K -- | 14.00K -- | 14.00K -- | 12.00K +140.00% | 7.00K -56.25% | 0 -100.00% | 0 -100.00% | 19.00K -- |
Change in Working Capital | 147.00K -- | -47.00K -131.97% | -2.07M -4310.64% | -2.34M -13.07% | 381.00K +116.25% | -2.00M -626.25% | -2.37M -18.25% | 12.82M +640.83% | -5.84M -145.57% | -15.29M -161.70% | -10.67M -- | 2.61M +117.08% | -15.59M -- | -21.82M -- | 20.87M +295.59% | 4.83M +84.91% | -14.60M +6.32% | 39.26M +279.90% | 50.35M -- |
Change in Accounts Receivable | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -13.07M -- | 8.96M -- | 4.66M -- | 650.00K -- | 5.00K +100.04% | 0 -100.00% | -165.00K -103.54% | -2.00K -100.31% | -162.00K -- |
Change in Inventories | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -3.20M -- | -1.17M -- | 7.27M -- | 0 -- | 0 +100.00% | 0 +100.00% | 0 -100.00% | 0 -- | -- -- |
Change in Contract liabilities | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.84M -- | -3.13M -- | -26.20M -- | -11.00K -- | 0 +100.00% | 0 +100.00% | 0 +100.00% | 0 +100.00% | -- -- |
Change in Other Working Capital | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 7.44M -- | -2.05M -- | -1.31M -- | -22.46M -- | 20.86M +180.54% | 4.83M +335.05% | -14.44M -999.70% | 39.26M +274.79% | 50.51M -- |
Other Non-cash Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 287.00K -- | 204.00K -- | 2.25M -- | 287.00K -- | 295.00K +2.79% | -5.09M -2597.55% | -3.62M -261.29% | 160.00K -44.25% | -8.26M -- |
Net Cash Flows from Investing Activities | -1.00K -- | -31.00K -3000.00% | -13.00K +58.06% | 11.28M +86900.00% | 451.00K -96.00% | -9.00K -102.00% | -36.00K -300.00% | -12.00K +66.67% | -84.00K -600.00% | -94.00K -11.90% | -178.00K -- | -23.00K +75.53% | 0 -- | -106.00K -- | 0 +100.00% | 185.00K +904.35% | 0 -- | -176.47M -166381.13% | -176.28M -- |
Change in PPE and Intangible Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -178.00K -- | -23.00K -- | 0 -- | -106.00K -- | 0 +100.00% | 185.00K +904.35% | 0 -- | 0 +100.00% | 185.00K -- |
Disposal of PPE and Intangible Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 185.00K -- | 0 -- | 0 -- | 185.00K -- |
Purchase of PPE and Intangible Assets | 1.00K -- | 31.00K +3000.00% | 54.00K +74.19% | 116.00K +114.81% | 31.00K -73.28% | 9.00K -70.97% | 36.00K +300.00% | 12.00K -66.67% | 84.00K +600.00% | 94.00K +11.90% | 178.00K -- | 23.00K -75.53% | 0 -- | 106.00K -- | 0 -100.00% | 0 -100.00% | 0 -- | 0 -100.00% | -- -- |
Change in Investments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | -176.47M -- | -- -- |
Increase in Investments | -- -- | -- -- | 9.96M -- | 0 -100.00% | 5.80M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | 176.47M -- | -- -- |
Net Cash Flows from Financing Activities | 940.00K -- | 41.41M +4305.43% | 41.00K -99.90% | 65.00K +58.54% | 6.47M +9850.77% | 0 -100.00% | 29.21M -- | 7.64M -73.83% | -611.00K -107.99% | 26.24M +4394.11% | 8.00K -- | -93.00K -100.35% | 239.13M -- | -182.00K -- | 98.20M +1227462.50% | 77.00K +182.80% | 383.38M +60.32% | 160.00K +187.91% | 481.83M -- |
Change in Debt | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -50.00K -- | -75.00K -- | -75.00K -- | -76.00K -- | -50.00K -- | 0 +100.00% | 0 +100.00% | -126.00K -- |
Repayment of long-term Debt | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 50.00K -- | 75.00K -- | 75.00K -- | 76.00K -- | 50.00K -- | 0 -100.00% | 0 -100.00% | 126.00K -- |
Change in Capital Stock | -- -- | -- -- | -- -- | 0 -- | 6.44M -- | 0 -100.00% | 19.00K -- | 8.76M +45978.95% | 0 -100.00% | 17.59M -- | 8.00K -- | -39.00K -100.22% | 239.20M -- | -107.00K -- | 98.28M +1228412.50% | 127.00K +425.64% | 383.25M +60.22% | 297.00K +377.57% | 481.95M -- |
Increase in Capital Stock | -- -- | -- -- | -- -- | 0 -- | 6.44M -- | 0 -100.00% | 19.00K -- | 8.76M +45978.95% | 0 -100.00% | 17.59M -- | 8.00K -- | 0 -100.00% | 239.20M -- | -107.00K -- | 98.28M +1228412.50% | 127.00K -- | 383.25M +60.22% | 297.00K +377.57% | 481.95M -- |
Decrease in Capital Stock | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 39.00K -- | 0 -- | 0 -- | 0 -- | 0 -100.00% | 0 -- | 0 -- | -- -- |
Other Financing Activities | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -4.00K -- | 4.00K -- | 0 -- | -- -- | 0 +100.00% | 137.00K +3325.00% | -137.00K -- | -- -- |
Net Increase in Cash and Cash Equivalents | 529.00K -- | 35.33M +6578.26% | -10.86M -130.73% | -3.17M +70.81% | -7.80M -146.23% | -17.16M -119.85% | 14.05M +181.88% | 5.84M -58.42% | -24.30M -516.15% | 15.24M +162.73% | -12.89M -- | -6.76M -144.34% | 135.35M -- | -36.98M -- | 68.79M +633.59% | -21.69M -220.83% | 342.42M +152.99% | -216.93M -486.55% | 172.60M -- |
Cash and Cash Equivalents at Beginning of Period | 185.00K -- | 22.80M +12222.16% | 62.56M +174.44% | 85.37M +36.45% | 60.81M -28.76% | 74.56M +22.61% | 60.27M -19.17% | 42.95M -28.74% | 62.27M +44.99% | 32.73M -47.44% | 48.67M -- | 35.78M +9.31% | 29.02M -- | 164.37M -- | 127.39M +161.73% | 196.18M +448.32% | 174.49M +501.31% | 516.91M +214.48% | 1.01B -- |
Cash and Cash Equivalents at End of Period | 714.00K -- | 58.12M +8040.62% | 51.70M -11.05% | 82.20M +58.98% | 53.01M -35.51% | 57.41M +8.29% | 74.31M +29.45% | 48.79M -34.35% | 37.97M -22.18% | 47.98M +26.35% | 35.78M -- | 29.02M -39.52% | 164.37M -- | 127.39M -- | 196.18M +448.32% | 174.49M +501.31% | 516.91M +214.48% | 299.99M +135.50% | 1.19B -- |
You can ask Aime
No Data
